HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.

AbstractOBJECTIVE:
To determine which first-line medication is more effective in polycystic ovary syndrome (PCOS) patients for ovulation induction and pregnancy achievement and to verify whether any patient characteristic is associated with a better response to therapy.
DESIGN:
Observational comparative study.
SETTING:
Fertility clinic.
PATIENT(S):
One hundred fifty-four infertile women with oligomenorrhea and hyperandrogenism.
INTERVENTION(S):
Group 1 (56 patients) received clomiphene citrate (CC) 50 mg from days 5-9 of the cycle. Group 2 (57 patients) received 500 mg of metformin 3 times a day. Group 3 (41 patients) received both medications.
MAIN OUTCOME MEASURE(S):
Ovulation and pregnancy.
RESULT(S):
Patients receiving metformin alone had an increased ovulation rate compared with those receiving CC alone (75.4% vs. 50%). Patients on metformin had similar ovulation rates compared with those in the combination group (75.4% vs. 63.4%). Pregnancy rates were equivalent in the 3 groups. Response to metformin was independent of body weight and dose. Finally, nonsmoking predicted better ovulatory response overall as well as lower fasting glucose for CC and lower androgens for metformin.
CONCLUSION(S):
Metformin is better for ovulation induction than CC alone and equivalent for pregnancy achievement. We suggest that metformin can be used first for ovulation induction in patients with PCOS regardless of their weight and insulin levels because of its efficacy and known safety profile.
AuthorsNathalie Neveu, Louis Granger, Pierre St-Michel, Hélène B Lavoie
JournalFertility and sterility (Fertil Steril) Vol. 87 Issue 1 Pg. 113-20 (Jan 2007) ISSN: 1556-5653 [Electronic] United States
PMID17081535 (Publication Type: Controlled Clinical Trial, Journal Article)
Chemical References
  • Drug Combinations
  • Fertility Agents, Female
  • Hypoglycemic Agents
  • Clomiphene
  • Metformin
Topics
  • Adult
  • Canada (epidemiology)
  • Clomiphene (administration & dosage)
  • Comorbidity
  • Drug Combinations
  • Female
  • Fertility Agents, Female (administration & dosage)
  • Humans
  • Hypoglycemic Agents (administration & dosage)
  • Infertility, Female (drug therapy, epidemiology)
  • Metformin (administration & dosage)
  • Ovulation Induction (methods)
  • Polycystic Ovary Syndrome (drug therapy, epidemiology)
  • Pregnancy
  • Pregnancy Outcome (epidemiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: